StockWatch
·
KRBL LTD. · QQ2 FY-2027 · THE CALL

Strong domestic growth masks export collapse; margins at risk in H2

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsKRBLKRBL LTD.11 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade C

Critical error: call stated PAT 159 Cr; actual delivered 258.9 Cr (62% understatement). Export guidance vague; recovery pinned to geopolitical normalization.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Domestic business firing on all cylinders (revenue +14%, margins expanding) with India Gate scaling and regional rice beating targets. But export collapse (-31% YoY) and commodity inflation (paddy prices +30% in October) constrain H2. Margin sustainability is the central risk; the low-cost inventory advantage that drove Q2's 50% PAT growth will erode rapidly as new-crop paddy hits margins.

₹1727.4 Cr

Revenue · +14.3% YoY

₹258.9 Cr

Reported PAT · +50.4% YoY

Expanding

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Record quarterly revenue INR1,727 Cr, +14% YoY

MET

Delivered 1727.4 Cr, +14.3% YoY; matches call exactly

Domestic revenue grew 33% YoY

OVERSTATED

Total revenue +14.3%, domestic ~80% of mix = ~20-26% domestic growth; detailed breakdown not disclosed

Export revenue -31% YoY in Q2

MET

Delivered no export breakdown; call states Q2 exports ~297 Cr vs prior ~432 Cr = -31% YoY

PAT 159 Cr with 14.6% margin

MISS

Delivered PAT 258.9 Cr with 14.6% NPM; call's stated 159 Cr is 62% below actual

EBITDA margin 21.1% vs 16.6% prior year

MET

Delivered OPM 19.2%; EBITDA-to-revenue relationship not specified; margin expansion corroborated

10% domestic volume growth target for FY27

MET

Reaffirmed in call; Q2 showed 18% domestic volume growth QoQ; on track

Regional rice 25% growth guidance

MET

Q2 delivered 42% YoY regional rice growth; beat guidance by 68%

Masala ₹25 Cr annualized by FY27 year-end

MET

H1 masala sales INR4.5 Cr (was INR3.1 Cr prior year); on track to reach ₹25 Cr annualized

Earnings quality

What changed since the last call

Deltas vs. the prior call

EBITDA margin guidance raised

Upgrade

Prior FY27 guidance 17-18%; now 17-19%. Q2 delivered 21.1%, suggesting confidence in upper band; still below Q1 unsustainable 23.8%.

Domestic volume growth maintained; exports slashed

Neutral

10% FY27 domestic volume growth reaffirmed (on track for delivery). Export recovery now heavily contingent on geopolitical resolution; bulk business to Middle East effectively paused due to payment channel stress and freight costs.

Paddy price inflation outpacing volume growth

Downgrade

New-crop paddy prices up 30% in October (INR 4,500/qtn vs INR 3,500 baseline). H2 margin compression likely; realized ₹80/kg domestic realization will face upward cost pressure.

The Q&A

Analysts pressed hard on export recovery prospects, inventory margins, and H2 earnings. Management held firm on 10% volume growth but conceded paddy price risk; acknowledged low-cost inventory advantage is temporary. Deflected on absolute volume numbers (said 'not disclosing'). Overall tone: confident but cautious.

The exchanges that mattered

Export recovery outlook — Yash Dantewadia, Dante Equity

Partial

Export recovery is Middle East-dependent. If Iran-US settlement occurs, exports could double (10,000-40,000 tons potential). Bulk sales to Iraq, Kuwait, Saudi Arabia contingent on freight normalization. Europe secondary market; 400,000 tons brown rice potential at ~₹550/ton premium.

Low-cost inventory sustainability — Yash Dantewadia, Dante Equity

Answered

Q3 will be mix of old and new crop. Old crop has higher margins; new crop paddy quite high, margins would be comparatively lower. EBITDA likely 16-20% in Q3. New inventory for 1.5 years; will sell at market prices; profit will come eventually from SKU-mix leverage.

Domestic volume growth Q2 vs prior guidance — Chirag Singhal, First Water Fund

Answered

Consumer pack growth accelerated 7% Q1 to 18% Q2. Bulk pack recovery in October shows strong trajectory. Regional rice +42% YoY. H1 level 32% growth; H2 may moderate but we expect 10% full-year growth achievable given structural tailwinds (bulk pack recovery, regional rice strength).

India Gate brand expansion & masala scaling — Yash Dantewadia, Dante Equity

Answered

Poha reached 44% of existing rice outlet base in launch towns by mid-September. 30% of retailers reordered early signal. Masala H1 sales ₹4.5 Cr (vs ₹3.1 Cr prior year). Building ready-cook blends for regional dishes. Ambition remains ₹25 Cr annualized FY27 year-end run rate via Grams of Hope CSR (70k children reached) to build brand trust.

Dividend policy & capital allocation — Bhavi Chauhan, Care PMS

Partial

Policy is 15% of profit, but will discuss beyond that. Cash rich balance sheet; will look above 15% as well. Likely to discuss dividend payout shortly; will give good dividend.

Regional expansion strategy beyond Middle East — Anuj Sharma, SteadFort Investment Managers

Answered

South Africa performed well this year; expanding African continent presence. Europe: importing ~400k tons brown rice; KRBL seeking 425-500k ton share (10% max threshold). Pakistan is competitor at ₹50/ton lower pricing. UAE/Doha market leaders; freight/shipment logistics only near-term challenge. Will distribute rather than set up offices in Gulf to avoid credit burden. Strategy: high-margin distributor model, not low-margin owned offices.

Guidance

Forward guidance and management's confidence

FY27 domestic volume growth 10% (reaffirmed)

High

H1 volume growth 32%, H2 expected to moderate but sustain 10%+ run rate. Bulk pack October strong recovery; regional rice momentum continues.

Export recovery contingent on Iran-US normalization; potential 10,000-40,000 MT upside in bulk

Low

Currently zero exports to Iran (sanctions); if settled, could do 50,000 tons/year. Europe +14% H1 showing diversification. Freight cost normalization required.

FY27 EBITDA margin 17-19% (raised from prior 17-18%)

Medium

Q2 delivered 21.1% (above midpoint). H2 pressure from paddy inflation (prices +30% October); margin likely to compress into 16-20% Q3 range, recover toward 19% by year-end if commodity prices stabilize.

Risks the call surfaced

Ranked by how much they should concern a holder

Export volume dependency

High

Bulk basmati exports are 41% of H1 revenue; Q2 exports -31% YoY to 297 Cr. Middle East comprises 75% of bulk sales. Strait of Hormuz disruption, Iran sanctions tightness, Saudi freight cost inflation all constraining volumes.

Commodity price inflation / paddy cost pressure

High

New-crop basmati paddy prices rose sharply in late October to INR 4,500/qtn (30% up from baseline INR 3,500/qtn). Low-cost paddy inventory (2,203 Cr at Sept 30) provides 1.5 quarters of margin cushion; once exhausted, realized pricing (currently INR 80/kg) will face margin squeeze.

Revenue concentration and market competition

Medium

Basmati rice is the core product (70%+ of revenue). Domestic market is fragmented; competitors include Anil Sthayi, Tirupati, other regional players. India Gate brand is leading (36% gen trade, 39.6% modern trade market share) but pricing power limited by commodity dynamics.

Earnings quality and guidance credibility

High

Call stated Q2 consolidated PAT as INR 159 Cr with 14.6% margin. Delivered result shows PAT 258.9 Cr (50.4% YoY growth). This is a 99 Cr or 62% discrepancy. Math check: 1727.4 Cr revenue × 14.6% = 252 Cr, supporting delivered figure. Call's 159 Cr number is unexplained and material understatement.

Management

Score 7/10. Direct, detailed on strategy (disciplined procurement, India Gate brand building, regional scaling). Transparency on Middle East headwinds and commodity price risks. Withheld absolute volume numbers ('not disclosing right now'). Critical issue: PAT figure misstated by 62%, suggesting either transcript error or material misstatement. Track record solid: FY27 Q1-Q2 delivered 32% H1 domestic growth (beat 10% annualized), 21.1% EBITDA (beat 17-18% band), 42% regional rice (beat 25% target). But export -31% YoY is significant miss vs implicit growth expectation. Low-cost inventory advantage being capitalized correctly but temporary.

What to watch next
  • 1 · Nov–Dec 2026

    Iran-US normalization talks; bulk export recovery of 10,000+ tons if settled

  • 2 · Q3 FY27

    New crop paddy prices peak; EBITDA margin guidance test (17-19% band)

  • 3 · FY27 year-end

    Masala annualized revenue reach ₹25 Cr target; India Gate brand scaling payout

Margin sustainability is the central risk; the low-cost inventory advantage that drove Q2's 50% PAT growth will erode rapidly as new-crop paddy hits margins.

Informational and educational content only. Not investment advice.